Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
Ukraine, US and Europe Seek Unified Peace Framework With Security Guarantees for Kyiv 
Judge Orders Return of Seized Evidence in Comey-Related Case, DOJ May Seek New Warrant 
U.S. Soldiers Killed in ISIS Attack in Palmyra, Syria During Counterterrorism Mission 
Neuralink Expands Brain Implant Trials with 12 Global Patients 
Indonesia–U.S. Tariff Talks Near Completion as Both Sides Push for Year-End Deal 
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission 
California, 18 States Sue to Block Trump’s $100,000 H-1B Visa Fee 
Preservation Group Sues Trump Administration to Halt $300 Million White House Ballroom Project 
New Epstein Photos Surface Showing Trump as Lawmakers Near Document Release Deadline 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced a bold plan to identify the cause of autism by September 2025. Speaking at a cabinet meeting with President Donald Trump, Kennedy declared a global research initiative involving hundreds of scientists to determine the source of rising autism rates, which reached 1 in 36 children by 2020, according to the CDC.
“We’ll know by September what has caused the autism epidemic and how to eliminate those exposures,” Kennedy said, hinting at environmental and artificial factors. The initiative is part of Trump’s broader “Make America Healthy Again” Commission, which is also reviewing rising childhood conditions like asthma and ADHD.
The autism community, however, responded with skepticism. Kristyn Roth of the Autism Society of America criticized the deadline and the framing of autism as an “epidemic,” warning it promotes fear and stigmatization. Experts caution that increased diagnoses are largely due to expanded diagnostic criteria and awareness, not an unknown epidemic.
Kennedy, known for promoting a disproven link between vaccines and autism, confirmed vaccines will be reviewed, along with potential environmental and lifestyle triggers. Meanwhile, a recent study has strengthened ties between prenatal diabetes and autism risk.
Controversy deepened after reports surfaced of David Geier—previously fined for unlicensed medical practices—being hired to investigate vaccine links. Lawmakers and advocacy groups fear the spread of misinformation under Kennedy’s leadership.
The National Institutes of Health and the CDC, both under Kennedy’s purview, are planning multimillion-dollar research efforts into autism causes, including vaccine-related studies. Critics argue the push may politicize science and mislead the public.
Despite widespread concern, Kennedy remains firm: “There will be no bigger news than finding the cause of autism.” Whether science can meet his deadline remains uncertain.
